Curcumin in various cancers (Q38072890)

28 August 2017

1 reference

title

Curcumin in various cancers (English)

1 reference

28 August 2017

0 references

Adeeb Shehzad

1

1 reference

28 August 2017

Jaetae Lee

series ordinal

2

1 reference

28 August 2017

Young Sup Lee

series ordinal

3

1 reference

28 August 2017

publication date

10 January 2013

1 reference

28 August 2017

1 reference

28 August 2017

volume

39

1 reference

28 August 2017

issue

1

1 reference

28 August 2017

page(s)

56-68

1 reference

Mutational heterogeneity in human cancers: origin and consequences.

28 August 2017

cites work

1 reference

21 January 2018

Cancer statistics, 2012

1 reference

New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases

21 January 2018

1 reference

Curcumin molecular targets in obesity and obesity-related cancers

21 January 2018

1 reference

Curcumin in Cancer Chemoprevention: Molecular Targets, Pharmacokinetics, Bioavailability, and Clinical Trials

21 January 2018

1 reference

Stability of curcumin in buffer solutions and characterization of its degradation products.

21 January 2018

1 reference

Comparative antioxidant activities of curcumin and its demethoxy and hydrogenated derivatives.

21 January 2018

1 reference

Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature

21 January 2018

1 reference

Curcumin therapeutic promises and bioavailability in colorectal cancer

21 January 2018

1 reference

Dose escalation of a curcuminoid formulation

21 January 2018

1 reference

Multitargeting by curcumin as revealed by molecular interaction studies

21 January 2018

1 reference

Design, synthesis, biological evaluation and molecular docking of curcumin analogues as antioxidant, cyclooxygenase inhibitory and anti-inflammatory agents

21 January 2018

1 reference

Fluorocurcumins as cyclooxygenase-2 inhibitor: molecular docking, pharmacokinetics and tissue distribution in mice

21 January 2018

1 reference

Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs

21 January 2018

1 reference

Curcumin inhibits Akt/mammalian target of rapamycin signaling through protein phosphatase-dependent mechanism

21 January 2018

1 reference

Curcumin induces c-jun N-terminal kinase-dependent apoptosis in HCT116 human colon cancer cells

21 January 2018

1 reference

Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe.

21 January 2018

1 reference

The inhibitory mechanism of curcumin and its derivative against beta-catenin/Tcf signaling

21 January 2018

1 reference

Anti cancer effects of curcumin: cycle of life and death

21 January 2018

1 reference

Curcumin promotes apoptosis, increases chemosensitivity, and inhibits nuclear factor kappaB in esophageal adenocarcinoma

21 January 2018

1 reference

Chemoprotective effects of curcumin in esophageal epithelial cells exposed to bile acids

21 January 2018

1 reference

Curcumin induces apoptosis-independent death in oesophageal cancer cells.

21 January 2018

1 reference

Curcumin induces cell death in esophageal cancer cells through modulating Notch signaling

21 January 2018

1 reference

Curcumin abrogates bile-induced NF-κB activity and DNA damage in vitro and suppresses NF-κB activity whilst promoting apoptosis in vivo, suggesting chemopreventative potential in Barrett's oesophagus.

21 January 2018

1 reference

Chemopreventive effect of curcumin on N-nitrosomethylbenzylamine-induced esophageal carcinogenesis in rats

21 January 2018

1 reference

Curcumin suppresses proliferation and invasion in human gastric cancer cells by downregulation of PAK1 activity and cyclin D1 expression

21 January 2018

1 reference

Curcumin attenuates gastric cancer induced by N-methyl-N-nitrosourea and saturated sodium chloride in rats

21 January 2018

1 reference

Curcumin inhibits the growth of AGS human gastric carcinoma cells in vitro and shows synergism with 5-fluorouracil

21 January 2018

1 reference

Role of curcumin in cancer therapy

21 January 2018

1 reference

Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis

21 January 2018

1 reference

Curcumin's effect on intestinal inflammation and tumorigenesis in the ApcMin/+ mouse

21 January 2018

1 reference

Curcumin for chemoprevention of colon cancer

21 January 2018

1 reference

Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance

21 January 2018

1 reference

Upregulation of p53 expression in patients with colorectal cancer by administration of curcumin

21 January 2018

1 reference

Prevention of intrahepatic metastasis by curcumin in an orthotopic implantation model

21 January 2018

1 reference

Curcumin-induced histone hypoacetylation: the role of reactive oxygen species

21 January 2018

1 reference

Mitochondrial and nuclear DNA damage induced by curcumin in human hepatoma G2 cells

21 January 2018

1 reference

Curcumin and liver cancer: a review

21 January 2018

1 reference

Curcumin inhibits SK-Hep-1 hepatocellular carcinoma cell invasion in vitro and suppresses matrix metalloproteinase-9 secretion

21 January 2018

1 reference

Nuclear factor-kappaB and IkappaB kinase are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis

21 January 2018

1 reference

Curcumin augments gemcitabine cytotoxic effect on pancreatic adenocarcinoma cell lines.

21 January 2018

1 reference

Activation of ATM/Chk1 by curcumin causes cell cycle arrest and apoptosis in human pancreatic cancer cells

21 January 2018

1 reference

Curcumin and cancer: an "old-age" disease with an "age-old" solution

21 January 2018

1 reference

Phase II trial of curcumin in patients with advanced pancreatic cancer

21 January 2018

1 reference

Effects of curcumin on bladder cancer cells and development of urothelial tumors in a rat bladder carcinogenesis model

21 January 2018

1 reference

Curcumin decreases specificity protein expression in bladder cancer cells

21 January 2018

1 reference

Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer

21 January 2018

1 reference

Curcumin, but not Prima-1, decreased tumor cell proliferation in the syngeneic murine orthotopic bladder tumor model

21 January 2018

1 reference

Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt.

21 January 2018

1 reference

Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through reactive oxygen species-mediated upregulation of death receptor 5 (DR5).

21 January 2018

1 reference

No prevention of liver and kidney tumors in Long-Evans Cinnamon rats by dietary curcumin, but inhibition at other sites and of metastases

21 January 2018

1 reference

Prostate cancer and curcumin: add spice to your life

21 January 2018

1 reference

Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo

21 January 2018

1 reference

Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines

21 January 2018

1 reference

Polyphenols: key issues involved in chemoprevention of prostate cancer

21 January 2018

1 reference

Curcumin attenuates β-catenin signaling in prostate cancer cells through activation of protein kinase D1.

21 January 2018

1 reference

Antitumor action of curcumin in human papillomavirus associated cells involves downregulation of viral oncogenes, prevention of NFkB and AP-1 translocation, and modulation of apoptosis

21 January 2018

1 reference

Molecular mechanism of curcumin induced cytotoxicity in human cervical carcinoma cells

21 January 2018

1 reference

Curcumin suppresses human papillomavirus oncoproteins, restores p53, rb, and ptpn13 proteins and inhibits benzo[a]pyrene‐induced upregulation of HPV E7

21 January 2018

1 reference

Curcumin-induced apoptosis in human leukemia cell HL-60 is associated with inhibition of telomerase activity

21 January 2018

1 reference

Curcumin inhibits prosurvival pathways in chronic lymphocytic leukemia B cells and may overcome their stromal protection in combination with EGCG.

21 January 2018

1 reference

Curcumin induces the apoptosis of human monocytic leukemia THP-1 cells via the activation of JNK/ERK pathways

21 January 2018

1 reference

Pure curcumin decreases the expression of WT1 by upregulation of miR-15a and miR-16-1 in leukemic cells

21 January 2018

1 reference

Curcumin suppresses constitutive activation of nuclear factor-kappa B and requires functional Bax to induce apoptosis in Burkitt's lymphoma cell lines.

21 January 2018

1 reference

Curcumin induces apoptosis and inhibits growth of human Burkitt's lymphoma in xenograft mouse model

21 January 2018

1 reference

Curcumin selectively induces apoptosis in cutaneous T-cell lymphoma cell lines and patients' PBMCs: potential role for STAT-3 and NF-kappaB signaling

21 January 2018

1 reference

Curcumin (Diferuloylmethane) Inhibits Constitutive and IL-6-Inducible STAT3 Phosphorylation in Human Multiple Myeloma Cells

21 January 2018

1 reference

Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis

21 January 2018

1 reference

Curcumin circumvents chemoresistance in vitro and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model

21 January 2018

1 reference

Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: a randomized, double-blind placebo-controlled cross-over 4g study and an open-label 8g extension study

21 January 2018

1 reference

The potential role of curcumin in patients with monoclonal gammopathy of undefined significance--its effect on paraproteinemia and the urinary N-telopeptide of type I collagen bone turnover marker

21 January 2018

1 reference

Curcumin induces small cell lung cancer NCI-H446 cell apoptosis via the reactive oxygen species-mediated mitochondrial pathway and not the cell death receptor pathway

21 January 2018

1 reference

Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1.

21 January 2018

1 reference

Curcumin reduces pulmonary tumorigenesis in vascular endothelial growth factor (VEGF)-overexpressing transgenic mice

21 January 2018

1 reference

Tumor-induced oxidative stress perturbs nuclear factor-kappaB activity-augmenting tumor necrosis factor-alpha-mediated T-cell death: protection by curcumin.

21 January 2018

1 reference

Cycle arrest and apoptosis in MDA-MB-231/Her2 cells induced by curcumin

21 January 2018

1 reference

Curcumin reverses breast tumor exosomes mediated immune suppression of NK cell tumor cytotoxicity

21 January 2018

1 reference

Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer

21 January 2018

1 reference

Curcumin induces G2/M cell cycle arrest in a p53-dependent manner and upregulates ING4 expression in human glioma

21 January 2018

1 reference

Curcumin: a potential neuroprotective agent in Parkinson's disease

21 January 2018

1 reference

Curcumin activated both receptor-mediated and mitochondria-mediated proteolytic pathways for apoptosis in human glioblastoma T98G cells

21 January 2018

1 reference

The curry spice curcumin selectively inhibits cancer cells growth in vitro and in preclinical model of glioblastoma

21 January 2018

1 reference

Curcumin promotes differentiation of glioma-initiating cells by inducing autophagy

21 January 2018

1 reference

Potent anti-inflammatory effects of systemically administered curcumin modulate periodontal disease in vivo.

21 January 2018

1 reference

Curcumin diminishes human osteoclastogenesis by inhibition of the signalosome-associated I kappaB kinase

21 January 2018

1 reference

In vivo modulation of signaling factors involved in cell survival.

21 January 2018

1 reference

Bioavailability of curcumin: problems and promises

21 January 2018

1 reference

Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers

21 January 2018

1 reference

Safety and pharmacokinetics of a solid lipid curcumin particle formulation in osteosarcoma patients and healthy volunteers

21 January 2018

1 reference

Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation

21 January 2018

1 reference

Innovative preparation of curcumin for improved oral bioavailability.

21 January 2018

1 reference

A Pilot Cross-Over Study to Evaluate Human Oral Bioavailability of BCM-95CG (Biocurcumax), A Novel Bioenhanced Preparation of Curcumin

21 January 2018

1 reference

Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/BIOF.1068

1 reference

28 August 2017

1 reference